Peptides that bind to the erythropoietin receptor
US8304391B2 · kind B2 · utility
1Cited by
58References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2009 |
| Grant date | Nov 6, 2012 |
| Priority date | — |
| Expiry date | Aug 24, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptide compounds that are agonists of the erythropoietin receptor (EPO-R) are described, as well as therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.